International Business Machines CorporationDownload PDFPatent Trials and Appeals BoardJan 27, 20212019005226 (P.T.A.B. Jan. 27, 2021) Copy Citation UNITED STATES PATENT AND TRADEMARK OFFICE UNITED STATES DEPARTMENT OF COMMERCE United States Patent and Trademark Office Address: COMMISSIONER FOR PATENTS P.O. Box 1450 Alexandria, Virginia 22313-1450 www.uspto.gov APPLICATION NO. FILING DATE FIRST NAMED INVENTOR ATTORNEY DOCKET NO. CONFIRMATION NO. 15/414,124 01/24/2017 Damir Anthony Jamsek CA920160063US1 7627 48150 7590 01/27/2021 MCGINN INTELLECTUAL PROPERTY LAW GROUP, PLLC 8321 OLD COURTHOUSE ROAD SUITE 200 VIENNA, VA 22182-3817 EXAMINER CALDWELL, ANDREW T ART UNIT PAPER NUMBER 2182 MAIL DATE DELIVERY MODE 01/27/2021 PAPER Please find below and/or attached an Office communication concerning this application or proceeding. The time period for reply, if any, is set in the attached communication. PTOL-90A (Rev. 04/07) UNITED STATES PATENT AND TRADEMARK OFFICE BEFORE THE PATENT TRIAL AND APPEAL BOARD Ex parte DAMIR ANTHONY JAMSEK and MAYSAM MIR AHMADI Appeal 2019-005226 Application 15/414,124 Technology Center 2100 Before JENNIFER L. McKEOWN, LINZY T. McCARTNEY, and MICHAEL T. CYGAN, Administrative Patent Judges. McCARTNEY, Administrative Patent Judge. DECISION ON APPEAL Appellant1 seeks review under 35 U.S.C. § 134(a) of the Examiner’s final rejection of claims 1, 2, 5–10, 13–17, 20, 21, and 24–26. We have jurisdiction under 35 U.S.C. § 6(b). We affirm. 1 Appellant identifies the real party in interest as International Business Machines Corporation. Appeal Brief 1, filed May 9, 2019 (Appeal Br.). Appeal 2019-005226 Application 15/414,124 2 BACKGROUND This patent application concerns “a linear system solving method,” in particular a method “for solving dense/sparse linear systems.” Specification ¶ 1, January 24, 2017 (Spec.). Claim 1 illustrates the claimed subject matter: l. A computer-implemented linear system solving method, the method comprising: calculating a matrix factorization for a matrix in a pair of matrices, in a form of a lower, a diagonal, and an upper (LDU) decomposition; first solving a first expression for a first value calculated from using the first expression using a substitution module based on the LDU decomposition to create a first result; dividing the first result by values stored in the diagonal of the matrix to obtain a second result; second solving a second expression for a second value calculated from using the second expression where a processing of the diagonal is skipped by using the second result; and determining a solution set for the pair of matrices in the linear system using the second expression, wherein the calculating proceeds to calculate a second matrix factorization for a second matrix while the first solving, the dividing, and the second solving are working with the matrix, and wherein the first solving and the second solving are performed using a same substitution module. Appeal Br. 13. REJECTION Claims 35 U.S.C. § References/Basis 1, 2, 5–10, 13–17, 20, 21, 24–26 101 Eligibility Appeal 2019-005226 Application 15/414,124 3 DISCUSSION We have reviewed the Examiner’s rejection and Appellant’s arguments, and Appellant has not persuaded us that the Examiner erred. As consistent with the discussion below, we adopt the Examiner’s reasoning, findings, and conclusions on pages 2–4 of the Final Office Action mailed January 17, 2019 (Final Act.), the continuation sheet of the Advisory Action mailed February 5, 2019 (Advisory Act.), and pages 3–5 of the Examiner’s Answer mailed June 12, 2019 (Ans.). I Section 101 of the Patent Act provides that “any new and useful process, machine, manufacture, or composition of matter, or any new and useful improvement thereof” is patent eligible. 35 U.S.C. § 101. But the Supreme Court has long recognized an implicit exception to this section: “Laws of nature, natural phenomena, and abstract ideas are not patentable.” Alice Corp. v. CLS Bank Int’l, 573 U.S. 208, 216 (2014) (quoting Ass’n for Molecular Pathology v. Myriad Genetics, Inc., 569 U.S. 576, 589 (2013)). To determine whether a claim falls within one of these excluded categories, the Court has set out a two-part framework. That framework requires us first to consider whether the claim is “directed to one of those patent-ineligible concepts.” Alice, 573 U.S. at 217. If so, we then examine “the elements of [the] claim both individually and ‘as an ordered combination’ to determine whether the additional elements ‘transform the nature of the claim’ into a patent-eligible application.” Alice, 573 U.S. at 217 (quoting Mayo Collaborative Servs. v. Prometheus Labs., Inc., 566 U.S. 66, 78, 79 (2012)). That is, we examine the claim for an “inventive concept,” “an element or combination of elements that is ‘sufficient to ensure that the patent in Appeal 2019-005226 Application 15/414,124 4 practice amounts to significantly more than a patent upon the [ineligible concept] itself.’” Alice, 573 U.S. at 217–18 (alteration in original) (quoting Mayo, 566 U.S. at 72–73). The United States Patent and Trademark Office has issued guidance about this framework. Under Office guidance, to determine whether a claim is directed to an abstract idea, we evaluate (1) whether the claim recites subject matter that either falls into one of three identified categories of abstract ideas or is a “tentative abstract idea,” and if so, (2) whether the additional elements of the claim integrate the abstract idea into a practical application. Manual of Patent Examining Procedure § 2106.04 (9th ed. latest rev. June 2020) (MPEP). If the claim is directed to an abstract idea, as noted above, we then consider whether the claim has an inventive concept. MPEP § 2106.05. When doing so, Office guidance explains that we should evaluate “whether any additional element or combination of elements are other than what is well-understood, routine, conventional activity in the field, or simply append well-understood, routine, conventional activities previously known to the industry, specified at a high level of generality.” MPEP § 2106.05(II). With this framework in mind, we turn to the Examiner’s rejection of claims 1, 2, 5–10, 13–17, 20, 21, and 24–26 under § 101. Appellant argues these claims together, so as permitted by 37 C.F.R. § 41.37(c)(1)(iv), we decide the appeal for this ground of rejection based on claim 1. II Office guidance identifies three categories of abstract ideas: certain methods of organizing human activity, mental processes, and mathematical concepts. MPEP § 2106.04(a). The Examiner determined that claim 1 recites subject matter that falls into the category of mathematical concepts because Appeal 2019-005226 Application 15/414,124 5 “[a]ll the steps of claim 1 call for a mathematical computation to be performed.” Final Act. 2. The Examiner then determined the claim 1 recites one additional element—a “substitution module”—and that this element does not integrate the recited mathematical concepts into a practical application because the element is a “[g]eneric computer component[]” that “perform[s] generic computer functions.” Final Act. 3; see also Ans. 3–4. Finally, the Examiner determined that claim 1 lacks an inventive concept because the additional element is a “generic element[]” that is “clearly well- understood, routine, and conventional.” Ans. 4; see also Final Act. 3. Appellant does not dispute that claim 1 recites mathematical concepts, nor does Appellant explicitly challenge the Examiner’s determination that the identified additional element is a generic component. Instead, Appellant asserts that “the Examiner failed to consider . . . whether” claim 1 “integrates the recited . . . [abstract idea] into a practical application.” Appeal Br. 9 (emphasis omitted). According to Appellant, claim 1 integrates the abstract idea into a practical application because the claimed method allegedly provides improvements such as “solving . . . dense or sparse matrices with virtually no overhead” and using a decomposition method that “that is better suited for stream processing,” among other things. Appeal Br. 10 (emphasis omitted). Appellant also contends that the last two steps in claim 1 “clearly define the solving of the linear system in a particular manner that improves the relevant technology.” Appeal Br. 10. Appellant has not persuaded us that the Examiner erred. Contrary to Appellant’s assertion, the Examiner considered whether claim 1 integrates the recited abstract idea into a practical application. As the Examiner explained in the Advisory Action, the Examiner addressed this issue as part Appeal 2019-005226 Application 15/414,124 6 of the “significantly more” analysis in the Final Office Action. Advisory Act., continuation sheet. And in the Answer, the Examiner again addressed whether claim 1 integrates the abstract idea into a practical application. Ans. 3–5. We thus disagree that the Examiner failed to perform this part of the § 101 analysis. As for Appellant’s argument that method recited in claim 1 integrates the abstract idea into a practical application because the method allegedly provides certain improvements, even if the claimed method provides the improvements that Appellant points to, claim 1 still would not be patent eligible. The method recited in claim 1 at best performs a particular mathematical operation (solving a linear system) faster and more efficiently than prior methods. See Appeal Br. 13; see also Appeal Br. 11 (arguing that the claimed method provides “a significant speed increase and overhead reduction in solving linear systems” (emphasis omitted)). “[T]hat is not enough for eligibility,” even assuming that the claimed method is “[g]roundbreaking, innovative, or even brilliant” and “novel and nonobvious.” SAP Am., Inc. v. InvestPic, LLC, 898 F.3d 1161, 1163 (Fed. Cir. 2018) (second alteration in original). This is because “[n]o matter how much of an advance in the [mathematics] field” the claimed method represents, “the advance lies entirely in the realm of abstract ideas” and thus “is ineligible for patenting.” SAP Am., Inc., 898 F.3d at 1163. In any event, Appellant’s arguments about the alleged improvements largely rest on an unclaimed element. Appellant repeatedly argues that an AHT-MAC architecture provides some of the alleged improvements. See, e.g., Appeal Br. 10–11. And the written description suggests that the alleged improvements flow at least in part from the AHT-MAC architecture. See, Appeal 2019-005226 Application 15/414,124 7 e.g., Spec. ¶ 39. But claim 1 does not recite an AHT-MAC architecture. See Appeal Br. 13. Improvements provided by disclosed but unclaimed elements do not make a claim patent eligible. See, e.g., Ariosa Diagnostics, Inc. v. Sequenom, Inc., 788 F.3d 1371, 1379 (Fed. Cir. 2015) (rejecting the suggestion that “the discovery of cffDNA in plasma or serum” provides an inventive concept when that discovery “is not the invention claimed by the . . . patent”); Am. Axle & Mfg., Inc. v. Neapco Holdings LLC, 967 F.3d 1285, 1293 (Fed. Cir. 2020) (“[W]e have repeatedly held that features that are not claimed are irrelevant as to step 1 or step 2 of the Mayo/Alice analysis.”). Appellant also contends that the Examiner erred because, in Appellant’s view, the last two steps in claim 1 “clearly include features that are not well-understood, routine, or conventional in the field and definitively include an inventive concept at least because these limitations are not taught in any prior art.” Appeal Br. 11 (emphasis omitted). Appellant also contends that the claim 1 is patent eligible because it “does not [preempt] the alleged abstract idea.” Reply Brief 4, filed June 25, 2019 (emphasis omitted). Appellant again fails to persuade us that the Examiner erred. The Examiner determined—and Appellant does not explicitly dispute—that the functions recited in the final two steps of claim 1 form part of the identified abstract idea. See Final Act. 2–3; Ans. 3. The Examiner was not required to find that parts of the identified abstract ideas were well understood, routine, and conventional. See, e.g., Bridge & Post, Inc. v. Verizon Commc’ns, Inc., 778 F. App’x 882, 892 (Fed. Cir. 2019) (“At Alice step two we assess ‘whether the claim limitations other than the invention’s use of the ineligible concept to which it was directed were well-understood, routine, and conventional.’” (quoting BSG Tech LLC v. BuySeasons, Inc., 899 F.3d 1281, Appeal 2019-005226 Application 15/414,124 8 1290 (Fed. Cir. 2018))); BSG Tech, 899 F.3d at 1290 (“[T]he relevant inquiry is not whether the claimed invention as a whole is unconventional or non-routine. . . . It has been clear since Alice that a claimed invention’s use of the ineligible concept to which it is directed cannot supply the inventive concept that renders the invention ‘significantly more’ than that ineligible concept.” (first emphasis added)). As for Appellant’s preemption argument, even assuming that claim 1 does not preempt all ways of performing the abstract idea, the absence of complete preemption does not demonstrate patent eligibility.” Ariosa Diagnostics, Inc., 788 F.3d at 1379. For at least the above reasons, Appellant has not persuaded us that the Examiner erred. We thus sustain the Examiner’s rejection of representative claim 1 under § 101. CONCLUSION Claims Rejected 35 U.S.C. § Rejection/Basis Affirmed Reversed 1, 2, 5–10, 13–17, 20, 21, 24–26 101 Eligibility 1, 2, 5–10, 13–17, 20, 21, 24–26 No period for taking any action in connection with this appeal may be extended under 37 C.F.R. § 1.136(a). See 37 C.F.R. § 1.136(a)(1)(iv). AFFIRMED Copy with citationCopy as parenthetical citation